We use cookies on this site to provide you with an informative and engaging experience and also to help us to continually improve our site for you. Without allowing cookies certain features of the site will not be available. To learn more about how we use cookies, please view our cookie policy. By clicking on ‘APPROVE’, you consent to our use of cookies on this device in accordance with our policy.
latest blogpost from the

KluwerCompetitionLawBlog

18 Aug 2017
by Adrian Emch

China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry

On 14 August 2017, the National Development and Reform Commission (“NDRC“) released a draft of the Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active Pharmaceutical Ingredients (“Draft Guidelines“).  NDRC is seeking comments on the Draft Guidelines until mid-September. One day later, NDRC made public the full text of its decisions... Continue reading The post China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry appeared first on Kluwer Competition Law Blog . …
All documents All Smart Chart sheets